Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - North American Scientific (NasdaqNM:NASI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
Aug 28Conference call: North American Scientific Earnings (Q3 2001)
Aug 28Earnings Announcement
Location
20200 Sunburst Street
Chatsworth, CA 91311
Phone: (818) 734-8600
Fax: (818) 734-5200
Email: investor.relations@nasi.net
Employees (last reported count): 51
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 18%
·Institutional: 40% (49% of float)
(60 institutions)
·Net Inst. Buying: 384.0K shares (+8.69%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
North American Scientific Inc. designs, develops and produces radioisotopic products, including brachytherapy seeds and radiopharmaceuticals, for the treatment and diagnosis of disease. The Company has applied its expertise in radioisotopes to develop and market products for medical, environmental, research and industrial applications. The Company's first two therapeutic products are iodine-based and palladium-based implantable brachytherapy seeds for the treatment of prostate cancer. These products are marketed under the trademarks IoGold and PdGold. The Company is also testing Apomate, an in vivo nuclear medicine imaging agent that targets cells undergoing apoptosis or necrosis, two forms of cell death.
More from Market Guide: Expanded Business Description

Financial Summary
North American Scientific manufactures and markets a line of low-level radiation sources and reference standards for medical, scientific and industrial uses, including the treatment of cancer and other diseases and the calibration of equipment. For the six months ended 4/30/01, net sales rose 11% to $9.4 million. Net loss totaled $246 thousand vs. an income of $2.6 million. Results reflect sales generated by the brachytherapy and non-therapeutic lines, offset by increased R&D expenses.

Recent Earnings Announcement
For the 3 months ended 07/31/2001, revenues were 4,851; after tax earnings were -1,832. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Irwin Gruverman, 67
Chairman
--  --  
L. Cutrer, 45
Pres, CEO, Director
$390K--  
Alan Edrick, 32
CFO
238K$265K
Dollar amounts are as of 31-Oct-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:NASIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 1-Mar-2001
$6.125
Recent Price$14.31 
52-Week High
on 29-Sep-2000
$31.75 
Beta1.07 
Daily Volume (3-month avg)44.8K
Daily Volume (10-day avg)31.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-43.6%
52-Week Change
relative to S&P500
-24.3%
Share-Related Items
Market Capitalization$144.7M
Shares Outstanding10.1M
Float8.30M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 2 on 1-May-1998
Per-Share Data
Book Value (mrq*)$6.97 
Earnings (ttm)-$1.66 
Earnings (mrq)-$0.18 
Sales (ttm)$2.09 
Cash (mrq*)$5.50 
Valuation Ratios
Price/Book (mrq*)2.05 
Price/EarningsN/A 
Price/Sales (ttm)6.84 
Income Statements
Sales (ttm)$18.8M
EBITDA (ttm*)-$7.92M
Income available to common (ttm)-$12.2M
Profitability
Profit Margin (ttm)-64.9%
Operating Margin (ttm)-48.8%
Fiscal Year
Fiscal Year EndsOct 31
Most recent quarter
(fully updated)
30-Apr-2001
Most recent quarter
(flash earnings)
31-July-2001
Management Effectiveness
Return on Assets (ttm)-23.07%
Return on Equity (ttm)-25.25%
Financial Strength
Current Ratio (mrq*)10.91 
Debt/Equity (mrq*)0.04 
Total Cash (mrq)$56.6M
Short Interest
As of 8-Aug-2001
Shares Short208.0K
Percent of Float2.5%
Shares Short
(Prior Month)
228.0K
Short Ratio13.87 
Daily Volume15.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-July-2001, except mrq*/ttm* items as of 30-Apr-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.